Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions

Neuron
M D NguyenJ-P Julien

Abstract

Recent studies suggest that increased activity of cyclin-dependent kinase 5 (Cdk5) may contribute to neuronal death and cytoskeletal abnormalities in Alzheimer's disease. We report here such deregulation of Cdk5 activity associated with the hyperphosphorylation of tau and neurofilament (NF) proteins in mice expressing a mutant superoxide dismutase (SOD1(G37R)) linked to amyotrophic lateral sclerosis (ALS). A Cdk5 involvement in motor neuron degeneration is supported by our analysis of three SOD1(G37R) mouse lines exhibiting perikaryal inclusions of NF proteins. Our results suggest that perikaryal accumulations of NF proteins in motor neurons may alleviate ALS pathogenesis by acting as a phosphorylation sink for Cdk5 activity, thereby reducing the detrimental hyperphosphorylation of tau and other neuronal substrates.

References

Sep 1, 1968·Neurology·S Carpenter
Sep 1, 1984·Journal of Neuropathology and Experimental Neurology·A HiranoG Saccomanno
May 1, 1995·Neurobiology of Aging·J LewJ H Wang
Feb 15, 1995·Neuroreport·J L Elliott, W D Snider
Aug 1, 1993·Neuropathology and Applied Neurobiology·P InceK G Baimbridge
Aug 12, 1993·Nature·J S BeckmanW H Koppenol
Jan 1, 1996·Annual Review of Neuroscience·M K Lee, D W Cleveland
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·T OhshimaA B Kulkarni
Nov 29, 1996·The Journal of Biological Chemistry·B I Giasson, W E Mushynski
Feb 1, 1997·Annals of Neurology·M E CudkowiczR H Brown
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·L B CorsonD W Cleveland
Jun 10, 1998·The Journal of Comparative Neurology·Y T Kwon, L H Tsai
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Couillard-DesprésJ P Julien
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·P PasinelliR H Brown
Oct 6, 1999·Current Opinion in Neurobiology·J P Julien
Dec 22, 1999·Nature·E Mandelkow
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·M K AhlijanianJ D McNeish
Apr 5, 2000·The Journal of Biological Chemistry·G KusakawaS Hisanaga
Apr 14, 2000·Brain Research. Molecular Brain Research· VeerannaG J Veeranna

❮ Previous
Next ❯

Citations

Mar 14, 2007·Human Genetics·Sumana GopinathGarth A Nicholson
Jan 10, 2008·Cellular and Molecular Neurobiology·Fatema A Dhariwala, Medha S Rajadhyaksha
Aug 8, 2008·Molecular Neurobiology·P S VoslerJ Chen
Mar 5, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Junfang WuAlan I Faden
Mar 23, 2004·Molecular and Cellular Neurosciences·Uk NamgungKyong-Tai Kim
Oct 16, 2003·Trends in Pharmacological Sciences·Charles KriegerSteven Pelech
Jun 5, 2003·Pharmacology & Therapeutics·Michael J Strong
Jan 22, 2002·Trends in Neurosciences·Holger Patzke, Li Huei Tsai
Oct 5, 2001·Trends in Genetics : TIG·H J Newbery, C M Abbott
Feb 22, 2003·Biochimie·Janice RobertsonJean-Pierre Julien
Feb 21, 2002·Trends in Cell Biology·Deanna S Smith, Li Huei Tsai
Jan 28, 2003·Drug Discovery Today·Peter M Mathisen
Jan 30, 2002·Trends in Molecular Medicine·Helen J Newbery, Catherine M Abbott
Jun 23, 2004·Nature Cell Biology·Minh Dang NguyenLi-Huei Tsai
Dec 14, 2004·The EMBO Journal·Ya-Li ZhengHarish C Pant
Jun 18, 2002·Journal of Neurochemistry·Jianwen ZhangGail V W Johnson
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Dylan W PetersonJohn Lew
Aug 17, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jing QuStuart A Lipton
Nov 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Lingyan ZhangJohn Lew
Feb 21, 2006·Antioxidants & Redox Signaling·Judith A Potashkin, Gloria E Meredith
Jun 12, 2002·Molecular Biology of the Cell·Diana M ToivolaM Bishr Omary
Jul 2, 2003·Molecular and Cellular Biology·Cecilia M SahlgrenJohn E Eriksson
Jun 26, 2004·Annual Review of Neuroscience·Lucie I BruijnDon W Cleveland
Jun 19, 2008·Annual Review of Neuroscience·Kurt J De VosChristopher C J Miller
Sep 24, 2011·Advances in Pharmacological Sciences·Varsha ShuklaHarish C Pant
Jun 19, 2009·Journal of Biomedical Science·Anne JämsäMervi Vasänge
Jan 17, 2008·PloS One·Timothy G LesnickDemetrius M Maraganore
Dec 3, 2003·Reviews in the Neurosciences·R Lalonde, C Strazielle
Apr 12, 2011·Reviews in the Neurosciences·Alejandro López-TobónGloria Patricia Cardona-Gómez
Nov 4, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Paola Giusti-RodríguezLi-Huei Tsai
Oct 22, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Diego PiedrahitaGloria Patricia Cardona-Gómez

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.